Macular Degeneration Foundation

Category: Study Results


Brolucizumab and Retinal Vasculitis

The intraocular inflammation that may occur after intravitreal therapy with brolucizumab (Beovu) can also be accompanied by retinal vasculitis severe enough to cause profound loss of vision, researchers have found. Source: American Academy of Ophthalmology (AAO). Linda Roach: EyeNet Magazine…

Read More

“Pitching” Blue Light Protective Eyewear

The Macular Degeneration Foundation published a Special Edition of its Newsletter in July of 2019. It detailed ten common misconceptions regarding macular degeneration. One was the idea that cell phones, televisions and computer screens damage the eyes with “blue light”….

Read More

How smoking can harm your eyes

Statistics have shown that only 1 out of 5 smokers actually are aware of the risk smoking has on their eye health. The following information may convince folks that breaking the habit is imperative to insure a long and healthy…

Read More

New Study Reveals Benefits of Augmented Reality Glasses

Source: Mark Humayun, MD, PhD, director of the USC Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics, codirector of the USC Roski Eye Institute and University Professor of Ophthalmology at the Keck School of Medicine. In a new study…

Read More

Common Misconceptions Regarding Macular Degeneration

True or False Image

by Dan RobertsMD Foundation Resource Director888-866-6148 Age-related macular degeneration (AMD) is a progressive disease of the retina wherein the light-sensing cells in the central area of vision (the macula) stop working and eventually die. The disease is thought to be…

Read More

Benefits of Aspirin Outweigh Risks in AMD Patients

Recent press releases regarding the potential adverse effects of aspirin on macular degeneration have caused patients with Age-related Macular Degeneration (AMD) to discontinue their aspirin use without consulting their physician. This study weighed the benefits that aspirin provides for patients’…

Read More